Although the exact mechanism for PAH inhibition of cGAS remains elusive, PAHs have been demonstrated to effectively inhibit cGAS-STING signaling and can be developed as therapeutics for the treatment of cGAS-mediated autoimmune diseases (Chu et al. 2021). Here, STING1 is linked to autoimmune disease.